BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
2501
Huya Inc
HUYA
$586M
| $67M | ﹤0.01% |
3,796,022
+341,842
| +10% | +$5.73M |
|
2502
CALL
Applied Materials
AMAT
$434B
| $66.9M | ﹤0.01% |
+469,900
| New | +$63.1M |
|
2503
Rayonier Advanced Materials
RYAM
$591M
| $66.8M | ﹤0.01% |
9,983,131
-98,907
| -1% | -$806K |
|
|
RNAM
2504
DELISTED
Avidity Biosciences
RNAM
| $66.7M | ﹤0.01% |
2,700,365
+10,638
| +0.4% | +$247K |
|
2505
CALL
ConocoPhillips
COP
$144B
| $66.7M | ﹤0.01% |
1,094,700
-263,500
| -19% | -$14.7M |
|
|
RDUS
2506
DELISTED
Radius Health, Inc.
RDUS
| $66.7M | ﹤0.01% |
3,654,721
-246,599
| -6% | -$4.9M |
|
2507
Atlanta Braves Holdings Series B
BATRK
$3.28B
| $66.6M | ﹤0.01% |
2,397,992
-273,240
| -10% | -$7.48M |
|
|
UMH
2508
UMH Properties
UMH
$1.3B
| $66.5M | ﹤0.01% |
3,049,367
+67,805
| +2% | +$1.45M |
|
2509
RLX Technology
RLX
$2.4B
| $66.4M | ﹤0.01% |
7,608,151
-5,415,303
| -42% | -$55.3M |
|
2510
Grupo Cibest SA
CIB
$21.4B
| $66.3M | ﹤0.01% |
2,302,840
-1,266,608
| -35% | -$39.1M |
|
|
ELAT
2511
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $66.3M | ﹤0.01% |
1,234,931
+15,191
| +1% | +$763K |
|
2512
Modine Manufacturing
MOD
$10.7B
| $66.2M | ﹤0.01% |
3,991,724
-151,524
| -4% | -$2.48M |
|
|
PRTY
2513
DELISTED
Party City Holdco Inc.
PRTY
| $66.2M | ﹤0.01% |
7,091,803
+5,209,565
| +277% | +$42.5M |
|
2514
IMAX
IMAX
$2.81B
| $65.9M | ﹤0.01% |
3,064,029
-45,926
| -1% | -$990K |
|
2515
SAP
SAP
$226B
| $65.7M | ﹤0.01% |
468,097
+59,366
| +15% | +$8.27M |
|
|
GOOD
2516
Gladstone Commercial Corp
GOOD
$608M
| $65.7M | ﹤0.01% |
2,912,629
+70,623
| +2% | +$1.51M |
|
2517
Theravance Biopharma
TBPH
$875M
| $65.6M | ﹤0.01% |
4,520,707
-113,428
| -2% | -$2.13M |
|
2518
Ranpak Holdings
PACK
$483M
| $65.5M | ﹤0.01% |
2,618,921
+173,013
| +7% | +$3.63M |
|
2519
PMV Pharmaceuticals
PMVP
$62.4M
| $65.5M | ﹤0.01% |
1,918,134
+492,261
| +35% | +$16.4M |
|
2520
CALL
Alphabet (Google) Class C
GOOG
$4.59T
| $65.4M | ﹤0.01% |
522,000
-760,000
| -59% | -$90.6M |
|
2521
Rhythm Pharmaceuticals
RYTM
$7.26B
| $65.3M | ﹤0.01% |
3,335,661
+190,301
| +6% | +$3.95M |
|
2522
Construction Partners
ROAD
$6.03B
| $65.1M | ﹤0.01% |
2,072,870
-115,674
| -5% | -$3.63M |
|
|
EPZM
2523
DELISTED
Epizyme, Inc
EPZM
| $65.1M | ﹤0.01% |
7,832,020
-560,038
| -7% | -$4.72M |
|
|
IDEX
2524
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $64.9M | ﹤0.01% |
+182,697
| New | +$65.2M |
|
|
2525
CALL
Apple
AAPL
$4.52T
| $64.8M | ﹤0.01% |
473,200
-329,800
| -41% | -$42.7M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.